BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16322299)

  • 1. Subcellular localization and protein levels of cyclin-dependent kinase inhibitor p27 independently predict for survival in epithelial ovarian cancer.
    Psyrri A; Bamias A; Yu Z; Weinberger PM; Kassar M; Markakis S; Kowalski D; Efstathiou E; Camp RL; Rimm DL; Dimopoulos MA
    Clin Cancer Res; 2005 Dec; 11(23):8384-90. PubMed ID: 16322299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the prognostic value of cellular inhibitor of apoptosis protein in epithelial ovarian cancer using automated quantitative protein analysis.
    Psyrri A; Yu Z; Bamias A; Weinberger PM; Markakis S; Kowalski D; Camp RL; Rimm DL; Dimopoulos MA
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1179-83. PubMed ID: 16775178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer.
    Psyrri A; Kassar M; Yu Z; Bamias A; Weinberger PM; Markakis S; Kowalski D; Camp RL; Rimm DL; Dimopoulos MA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8637-43. PubMed ID: 16361548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.
    Masciullo V; Ferrandina G; Pucci B; Fanfani F; Lovergine S; Palazzo J; Zannoni G; Mancuso S; Scambia G; Giordano A
    Clin Cancer Res; 2000 Dec; 6(12):4816-22. PubMed ID: 11156240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic p27 expression is an independent prognostic factor in ovarian cancer.
    Duncan TJ; Al-Attar A; Rolland P; Harper S; Spendlove I; Durrant LG
    Int J Gynecol Pathol; 2010 Jan; 29(1):8-18. PubMed ID: 19952944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis.
    Kountourakis P; Psyrri A; Scorilas A; Markakis S; Kowalski D; Camp RL; Diamandis EP; Dimopoulos MA
    Thromb Haemost; 2009 Mar; 101(3):541-6. PubMed ID: 19277417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer.
    Hurteau JA; Allison BM; Brutkiewicz SA; Goebl MG; Heilman DK; Bigsby RM; Harrington MA
    Gynecol Oncol; 2001 Nov; 83(2):292-8. PubMed ID: 11606087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.
    Rosen DG; Yang G; Cai KQ; Bast RC; Gershenson DM; Silva EG; Liu J
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):632-7. PubMed ID: 15701850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical study.
    Baekelandt M; Holm R; Tropé CG; Nesland JM; Kristensen GB
    Clin Cancer Res; 1999 Oct; 5(10):2848-53. PubMed ID: 10537352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.
    Psyrri A; Yu Z; Weinberger PM; Sasaki C; Haffty B; Camp R; Rimm D; Burtness BA
    Clin Cancer Res; 2005 Aug; 11(16):5856-62. PubMed ID: 16115926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
    Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
    Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 expression indicates favorable prognosis in epithelial ovarian cancer.
    Sillanpää S; Anttila MA; Voutilainen K; Tammi RH; Tammi MI; Saarikoski SV; Kosma VM
    Clin Cancer Res; 2003 Nov; 9(14):5318-24. PubMed ID: 14614016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment and prognostic factors for stage IV epithelial ovarian cancer].
    Wu M; Shen K; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
    Le T; Alshaikh G; Hopkins L; Faught W; Fung MF
    Ann Surg Oncol; 2006 Dec; 13(12):1711-6. PubMed ID: 17009146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
    Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
    Oncol Rep; 2006 Apr; 15(4):765-71. PubMed ID: 16525656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of cytoplasmic p27 expression in human melanoma.
    Chen G; Cheng Y; Zhang Z; Martinka M; Li G
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of Skp2 and p27 in human breast cancer.
    Traub F; Mengel M; Lück HJ; Kreipe HH; von Wasielewski R
    Breast Cancer Res Treat; 2006 Sep; 99(2):185-91. PubMed ID: 16636894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma.
    Yu Z; Weinberger PM; Haffty BG; Sasaki C; Zerillo C; Joe J; Kowalski D; Dziura J; Camp RL; Rimm DL; Psyrri A
    Clin Cancer Res; 2005 Feb; 11(3):1160-6. PubMed ID: 15709184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
    Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.